XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.4
STOCKHOLDERS’ EQUITY (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Feb. 13, 2023
Dec. 31, 2022
Nov. 30, 2022
Mar. 31, 2021
Feb. 28, 2021
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Stockholders’ Deficit (Details) [Line Items]                
Preferred stock, shares authorized (in shares)   10,000,000         10,000,000 10,000,000
Preferred stock, par value (in dollars per share)   $ 0.001         $ 0.001 $ 0.001
Preferred stock, shares outstanding (in shares)   0         0 0
Common stock, shares authorized (in shares)   100,000,000         100,000,000 100,000,000
Common stock, par value (in dollars per share)   $ 0.001         $ 0.001 $ 0.001
Common stock sold (in shares)     67,572 98,750 198,443      
Common stock sold, price per share (in dollars per share)     $ 3.50 $ 40.00 $ 45.57 $ 40.00    
Number of warrants (in shares)   4,414,685         4,414,685  
Exercise price per share (in dollars per share)   $ 6.58         $ 6.58  
Warrants, exercised (in shares)             131,000 35,059
Common stock sold, gross proceeds           $ 3,950    
Common Stock                
Stockholders’ Deficit (Details) [Line Items]                
Stock issued, warrants exercised (in shares)             131,000  
Common Stock Warrants Issued In November 2022                
Stockholders’ Deficit (Details) [Line Items]                
Gross proceeds, warrants exercised     $ 5,000          
Pre-Funded Warrants                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)   $ 3.50 $ 3.50       $ 3.50  
Warrants, exercised (in shares)   131,000           0
Pre-Funded Warrants | Common Stock | Subsequent Event                
Stockholders’ Deficit (Details) [Line Items]                
Stock issued, warrants exercised (in shares) 1,230,000              
Pre-Funded Warrants | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)     1,361,000          
Series A and Series B Warrants Issued in November 2022 Common Stock Registered Direct Offering                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)     $ 3.165          
Series A and Series B Warrants Issued in November 2022 Common Stock Registered Direct Offering | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)     2,857,144          
Warrants Issued in November 2022 Common Stock Registered Direct Offering | H.C. Wainwright & Co., LLC                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)     $ 4.375          
Warrants Issued in November 2022 Common Stock Registered Direct Offering | Maximum | H.C. Wainwright & Co., LLC                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)     107,143          
Warrants Issued to Placement Agent in March 2021 Registered Direct Offering | H.C. Wainwright & Co., LLC                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)       $ 50.00   $ 50.00    
Warrants Issued to Placement Agent in March 2021 Registered Direct Offering | Maximum | H.C. Wainwright & Co., LLC                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)       7,408   7,408    
Warrants Issued in February 2021 Private Placement Agreement                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)         $ 44.32      
Gross proceeds, warrants exercised         $ 10,000      
Warrants Issued in February 2021 Private Placement Agreement | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)         109,730      
Common Stock, Pre-Funded Warrants Issued in February 2021 Private Placement Agreement                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)         $ 2.2775      
Distributed (in shares)               420,000
Common Stock, Pre-Funded Warrants Issued in February 2021 Private Placement Agreement | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)         21,000      
Common Stock, Associated Warrants Issued in February 2021 Private Placement Agreement | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)         109,730      
Warrants Issued to Placement Agent in February 2021 Private Placement Agreement                
Stockholders’ Deficit (Details) [Line Items]                
Exercise price per share (in dollars per share)         $ 2.8481      
Warrants Issued to Placement Agent in February 2021 Private Placement Agreement | H.C. Wainwright & Co., LLC                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)         16,460      
Exercise price per share (in dollars per share)         $ 56.96      
Warrants Issued to Placement Agent in February 2021 Private Placement Agreement | Maximum                
Stockholders’ Deficit (Details) [Line Items]                
Number of warrants (in shares)         329,164